Immuneering (IMRX) Share-based Compensation (2020 - 2026)
Immuneering's Share-based Compensation was $1.63 million in Q2 2026, up 6.8% from $1.52 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Share-based Compensation (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Share-based Compensation was $6.36 million through Jun 30, 2026, down 3.4% year-over-year; for FY2025, it came in at $6.31 million, down 2.9% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 42.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $6.5 million in FY2024 (+13.5%), $5.73 million in FY2023 (+40.9%), $4.06 million in FY2022 (+125.5%) and $1.8 million in FY2021 (+65.9%).
- Quarterly Share-based Compensation has moved between $632,583 (Q4 2021) and $1.72 million (Q4 2024) over five years.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 1.2%.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 392.6%); the worst was Q3 2025 (a decline of 11.2%).
- Per Business Quant data, IMRX's Share-based Compensation in the three quarters before Q2 2026 was $1.64 million (Q1 2026), $1.64 million (Q4 2025) and $1.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Immuneering | 269.14 Mn | 269.14 Mn | - | 1.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 897,650.00 |
| Dec 31, 2021 | 632,583.00 |
| Sep 30, 2021 | 636,806.00 |
API Access
Immuneering Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();